organovo

Featured

Bioprinting Battle Ends: BICO and Organovo Come to Licensing Agreement

The clash between bioprinting pioneer and powerhouse have come to an end. San Diego, California-based Organovo Holdings, Inc. (Nasdaq: ONVO) and Gothenburg, Sweden-based BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) have…

Harvard Bioprinting Tech Licensed to Ex-Organovo Execs for Bioprinted Kidneys

San Diego-based Trestle Biotherapeutics has initiated an agreement with Harvard University to license the school’s stem cell and bioprinting technology. The goal is to 3D print kidney tissue for regenerative…

Featured

Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over

In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…

Featured

AMS 2021: Deconstructing the Timeline to Bioprinted Organs

Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel…

Featured

Top 10 Bioprinting Stories of 2020: Paving the Way to Future Organ Transplants

New research and developments in biotechnology in 2020 are helping to shape biomedical engineering. Although there are many challenges that still need to be addressed, key advances are proving the…

Featured

Organovo’s Keith Murphy Back as Executive Chairman

Founder and former CEO of Organovo, Keith Murphy, is back as the company’s newly appointed Executive Chairman of the Board. The news comes three years after Murphy left the pioneering…

Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discovery

Biotechnology companies are uncovering new methods to develop drugs across a range of therapeutic areas. Looking to demonstrate a commitment to drug discovery and moving away from traditional laboratory animal…

Keith Murphy: “We Believe We are Discovering the Next Step in Drug Development”

It’s been three years since Keith Murphy and Jeffrey Miner joined forces to create the biotechnology company Viscient Biosciences. In 2017, the co-founders had recently left their previous successful enterprises…

Organovo’s Merger Deal with Tarveda Falls Through, for Now

It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…

Former CEO of Organovo Urges Stockholders Against Merger with Tarveda

Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…

Organovo Presents New Data on Stem Cell-Based Bioprinted Kidney Organoids 

Pioneer bioprinting company Organovo presented new findings in their stem-cell-based approach to developing kidney tissue using its 3D bioprinting platform, the NovoGen Bioprinter. During the annual meeting for The International…

Organovo: Bioprinting Could be the New Solution to Organ Transplantation

Remember when movies like The Island seemed like a scary yet foreseeable future? In 2005, the sci-fi thriller introduced a compound inhabited by clones used for organ harvesting, as well…

R&D Profiles of Leading 3D Printing Companies

It is important to analyze the level of the R&D occurring at the leading 3D printer manufacturers to help understand the technology commitment and future growth prospects of the 3D…

3D Printing News Briefs: December 27, 2017

Just because Christmas was two days ago doesn’t mean that the 3D printing industry has been taking a break. In today’s 3D Printing News Briefs, we’ll be covering the latest…

Organovo & Viscient Biosciences Collaborate for 3D Bioprinting in Liver Disease Research

Earlier this month, both Organovo and Viscient Biosciences announced their intent to collaborate on research for further studies into liver disease. There have been many interesting stories about Organovo and…

3D Printing News Briefs: October 13, 2017

It’s Friday the 13th – instead of walking under ladders, breaking mirrors, or generally going outside at all, it’s probably safest to stay in and read today’s edition of 3D…

NIH Grant Awarded to Organovo to Use Its 3D Printed Liver Tissue to Study Liver Disease with UC San Diego

California-based bioprinting company Organovo is well-known to those in both the 3D printing and medical research worlds, due to its 3D printed kidney and liver tissues. The company, which previously announced…

New $250,000 Cash R&D Tax Credit Ideal for 3D Bioprinting

3D printing has become a revolutionizing industry in hundreds of areas like commercial products and engineering, but the development has been especially notable in the biomedical field. It is being…

Organovo’s 3D Printed Liver Tissue Shows Extended Survival and Function in Animal Test Subjects

Organovo is a well-known company to anyone involved in 3D printing, tissue engineering or both. While many are familiar with the company’s 3D printed liver and kidney tissues, however, it’s…

The R&D Profiles of Leading 3D Printing Companies

It is important to analyze the level of the R&D occurring at the leading 3D printer manufacturers to help understand the technology commitment and future growth prospects of the 3D…

Organovo and University of Virginia Team Up to Address Volumetric Muscle Loss Through 3D Printing

The human body is remarkably resilient, but sometimes injuries or illnesses are so severe that it can’t repair itself, at least not completely. Such is the case with volumetric muscle…

More 3D Printing Executive Transitions as Organovo CEO Keith Murphy Steps Down, to be Replaced by Taylor J. Crouch

This year has been a tumultuous one in the 3D printing industry so far. January saw the resignation of MakerBot CEO Jonathan Jaglom, who was replaced by Nadav Goshen, and…

Organovo Presents Data on 3D Printed Kidney and Liver Tissue at Society of Toxicology Annual Meeting

We received our last update on 3D bioprinting company Organovo a couple of weeks ago, when it released a plethora of new information regarding the performance of its 3D printed kidney…

Recently Released Studies Show Increasing Promise of Organovo 3D Printed Kidney and Liver Tissue for Pharmaceutical Testing

If you’re only marginally familiar with bioprinting and have heard of just one company in the industry, it’s likely that company is Organovo. The San Diego company was one of the…